Showing results (201-210 of 353) with videos related to
Sort By:
Pageof 36
Archives of Pathology & Laboratory Medicine|December 7, 2023
T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic FeaturesSiba El Hussein, Hong Fang, Fatima Zahra Jelloul, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2015
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†C Casulo, B Day, K L Dawson, et al.British Journal of Haematology|June 13, 2002
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphomaJonathan W Friedberg, Donna Neuberg, John G Gribben, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomasJonathan W Friedberg, Daruka Mahadevan, Erin Cebula, et al.Rand Health Quarterly|January 14, 2017
Effects of Health Care Payment Models on Physician Practice in the United StatesMark W Friedberg, Peggy G Chen, Chapin White, et al.Seminars in Oncology|February 24, 2005
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary reportG L Phillips, C N Abboud, S H Bernstein, et al.Blood|October 18, 2017
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HLJonathan W Friedberg, Andres Forero-Torres, Rodolfo E Bordoni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2008
Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer NetworkAnn S LaCasce, Michelle E Kho, Jonathan W Friedberg, et al.Journal of Oncology Practice|October 1, 2015
Lessons From Early Implementation of a Patient-Centered Care Model in OncologyManasi A Tirodkar, Nicole Acciavatti, Lindsey M Roth, et al.Leukemia & Lymphoma|April 23, 2004
Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphomaJennifer R Brown, Guylaine Gaudet, Jonathan W Friedberg, et al.Pageof 36